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Abstract 
In 2011 Celardo et al. [1] demonstrated that the antioxidant capacity of cerium oxide nanoparticles 
(CeOx NPs) was dependent on the population of Ce3+ ions within the nanoparticle. In the cellular 
environment the nanoparticles were able to quench free radicals through cyclic redox reactions of 
the Ce3+ ions. The consequence being the larger the Ce3+ ion population of included NPs the larger 
the resultant cell growth of the assayed cell line.  The goal of this thesis was to reproduce these 
findings and determine whether this dependency also translated to radiation protection efficacy 
under megavoltage (MV) x-ray radiation. Two-thirds of cell death inflicted by MV x-rays is achieved 
through the generation of free radical species. It therefore stands that controlling the population of 
Ce3+ ions within CeOx NPs should control their ability to protect against radiation damage. 
Cerium oxide nanocrystalline particles were synthesised by spray pyrolysis. To modulate the 
population of Ce3+ ions the NPs were doped with iron (Fe3+). 5 %, 10 % and 20 % atomic 
concentrations variants were synthesised. The nanoparticles were characterised using x-ray 
diffraction (XRD), optical emission spectroscopy (OES), transmission electron microscope (TEM) and 
x-ray photoelectron spectroscopy (XPS). XRD showed all crystallites to be of a single phase and built 
of a cubic fluorite structure consistent with the formation of cerium oxide. Crystallites were all 
within the range of 5-10 nm. A reducing lattice parameter with increased iron doping confirmed the 
inclusion of the Fe3+ ions within the cerium oxide lattice. Rietveld refinement determine the 
minimum lattice parameter to be 5.416 Å suggesting inclusion of Ce3+ ions for all particles. Actual 
Fe3+ doping was found to be within 0.5 % of target concentration for all particles except the 20 % 
iron doped variant which experienced 1% iron loss as a result of surpassing the crystal solubility 
limit.   
Global assessment of nanocrystalline particles using XPS showed a decreasing population of Ce3+ 
ions with increasing Fe3+ ion inclusion. 18 % atomic concentration of Ce3+ ions in pure cerium oxide 
particles reduced to ~8 % for the 20 % iron doped variant.  
Clonogenic assays using 9L gliosarcoma cells assessed the ability of CeOx NPs to boost cell growth 
and protect against megavoltage x-ray damage. With no radiation pure CeOx NPs provided a 10 % 
boost to cell growth. When 8 Gy of 10 MV x-rays was delivered to the cell monolayer the CeOx NP 
inclusion improved cell survival by 75 %. Increasing the radiation survival fraction from 0.12 to 0.22.  
The inclusion of the 5 % Fe doped CeOx NPs boosted cell growth by 6 % and increased the radiation 
survival fraction by 20 %. 10 % Fe doped CeOx NPs did not significantly boost cell growth or improve 
radiation survival fraction. 20 % Fe doped CeOx NPs reduced cell growth by 12 % and were not used 
in radiation studies.   
Overall these studies suggest that radioprotection efficacy of cerium oxide nanoparticles is 
dependent on the population of Ce3+ ions. The correlation between nanoparticle Ce3+ population, 
cell growth and cell survival fraction provide clear and comprehensive evidence of this dependency.  
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Chapter 1  
Hypothesis and Objectives 
1.1 Hypothesis of thesis 
The radioprotection efficacy of cerium oxide nanoparticles is dependent upon the population of 
Ce3+ ion within the crystal lattice. 
1.2 Objectives of thesis 
The fundamental objectives and aims of this thesis were to: 
• synthesise pure and iron doped cerium oxide nanoparticles, 
• characterise pure and iron doped cerium oxide nanoparticles; 
• assess the antioxidant behaviour of pure and iron doped cerium oxide nanoparticles 
included in a 9L cell line; and 
• assess the radioprotection given to a 9L cell line by pure and iron doped cerium oxide 
nanoparticles when irradiated with 10 MV x-rays. 
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Chapter 2  
Literature Review 
2.1 Cancer 
Cancer is a disorder characterised by the continual proliferation of cells. Ordinarily cell death would 
counter cell growth however, cancer cells divide quicker than they die; invading adjacent tissues 
and damaging the organs of an organism. This outcome arises from the mutation of the genetic 
material within cancer cells and an inability of the body to recognise and destroy the cancer cells 
[2]. Cancer cells can be characterised by the following unique features:  
• Clonal origin. Most cancer cells arise from one abnormal cell formed due to field damage or 
heritable defects in some genes. 
•  Immortality.  Unlike normal cells cancer cells can undergo an unlimited number of divisions. 
One of the mechanisms for immortality is associated with telomeres; the tips of 
chromosomes. In normal differentiated cells telomeres shorten with division until the cell 
goes into a resting state and consequently dies. In cancer cells and stem cells the telomerase 
enzyme renews telomeres allowing the cells to proliferate indefinitely. 
•  Genetic instability. This situation is caused by defects in the DNA repair process and in the 
DNA mismatch recognition, which results in the heterogeneity of cancer cells. Cancer cells 
form clones that gradually respond less to proliferation control and become hardier in 
foreign environments. 
• Loss of contact inhibition. In-vitro studies show normal cells stop dividing once they have 
exhausted space no matter the quantity of growth factors and nutritional elements. Cancer 
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cells continue to divide independent of surface contact and will grow in multiple layers until 
resources are exhausted causing their subsequent death. 
• Metastasis. This feature is not found in benign tumours and normal cells. Metastasis is 
caused by breakdown in adherence mechanism to the extracellular matrix, intercellular 
interactions and destruction of connective membranes such as the basal layer.  
The 2017 report by the Australian Institute of Health and Welfare (AIHW) estimated that 134,174 
Australians will be diagnosed with cancer for the year. More than half of those cases would be for 
males and 71% for those aged 60 years and over. The most commonly reported cancers in this year 
would be, in order of prevalence, breast, bowel, prostate and melanoma cancer. The report finishes 
by noting, that according to the World Health Organization (WHO) people living in Australia 
generally had better cancer survival than people in other regions about the world. This is attributed 
to government funding into health education, early detection programs and access to 
comprehensive healthcare [3]. 
2.2 Cellular effects of radiation 
All molecules within a cell can be damaged by ionising radiation (IR) however, DNA molecules that 
carry genetic information relating to cell division and growth are the most critical structures. Over 
the years target studies on individual cells have shown radiation to be most lethal when it targets 
the nucleus of a cell [4]. While there are many copies of mRNA, water and proteins there are only 
two copies of DNA. Radiation may damage one or several locations on the helix structure resulting 
in damage to bases and/or the phosphate backbone strands. Depending on the extent of the 
damage several outcomes are possible:  
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1. The DNA is successfully repaired and the cell continues to proliferate 
2. The DNA is not repaired and the cell dies (controlled or uncontrolled) 
3. The DNA is incorrectly repaired leading to death in a future generation (controlled or 
uncontrolled) 
4. The DNA is incorrectly repaired leading to the formation of cancer 
The interaction of therapeutic x-ray beams (MV) in tissue is primarily down to Compton scatter with 
minor contribution from photoelectric absorption and pair production. Photons ionise/excite 
electrons within molecules and macromolecules contained within the cell. The ejection of these 
electrons affects chemical change, causing bonds to be broken. If enough bonds are broken within 
the DNA or repair molecules the cell may be unable to function correctly leading to apoptotic or 
mitotic death [5].  
The cell damage occurs through direct and indirect interaction as shown in Figure 2-1. Direct action 
sees ‘ejected’ secondary electrons cause further ionisation in the molecules they collide with, 
progressively slowing down as they go. At the end of these electron tracks there is clustering of 
ionisation events [6]. The clustering causes many breaks along the DNA helix structure. It has been 
found that breaks to both strands within 4 base pairs will greatly increase chance of cell death [7].  
Indirect damage is the result of interaction of IR with the cytoplasm which create reactive chemical 
species that attack the DNA and other vital structures as shown in Figure 2-1. As much of a cell is 
made of water the majority of indirect damage is mediated through the ionisation of the water 
molecule. The water molecule is ionised to produce an ion pair of H2O+ and H2O-. Each is unstable 
and dissociates to form another ion and a free radical as shown in chemical equation 2-1 and 
Equation 2-2. Free radicals are neutral molecules with a lone electron and highly reactive. 
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Figure 2-1: DNA is damaged direct by secondary electrons and indirectly by free radicals [8]. 
 
Free radicals can work as oxidising or reducing agents by combining directly with macromolecules 
like DNA. H+ and OH- ions do not typically produce much biological damage owing to the short 
lifetime of ~10
-10 s and their tendency to recombine to form water (Equation 2-3).  
Equation 2-1             𝐻2𝑂
+ →  𝐻+ + 𝑂𝐻⦁ 
Equation 2-2         𝐻2𝑂
− →  𝐻⦁ + 𝑂𝐻+  
Equation 2-3         𝐻+ + 𝑂𝐻− →  𝐻2𝑂 
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The free radicals H⦁ and OH⦁ may also recombine to form water (Equation 2-4) however in the 
presence of oxygen this is less likely to occur as oxygen stabilises free radicals. Instead these radicals 
could form hydrogen peroxide (Equation 2-5), a natural occurring chemical product of metabolism 
that is linked to apoptotic death. Oxygen itself could react with a hydrogen radical to form a 
hydroperoxyl radical (Equation 2-6) or it could be reduced by a lone electron to form the superoxide 
ion (Equation 2-7). There are a multitude of further ions and radicals that can be produced; these 
include nitrous and organic compounds. While the lifetime of these species might only be ~10
-5 s 
they can diffuse throughout the cell causing damage at locations remote form their origin [9].  
Equation 2-4         𝐻⦁ + 𝑂𝐻⦁ →  𝐻2𝑂 
Equation 2-5         𝑂𝐻⦁ + 𝑂𝐻⦁ →  𝐻2𝑂2 
Equation 2-6         𝐻⦁ + 𝑂2 → 𝐻𝑂2 
Equation 2-7         𝑂2 + 𝑒
− → 𝑂2⦁
− 
Roughly two thirds of cell damage caused by MV photons on mammalian cells lines is caused by in-
direct ionisation [10]. The dependence of MV photons on indirect action makes it less effective when 
dealing with hypoxic cells however in most cases this dependency can be greatly reduced through 
fractionation.  
2.3 Radiation Therapy 
Radiation therapy or radiotherapy uses ionising radiation to deliver a prescribed dose to a tumour 
while ensuring radiation dose to surrounding normal tissue is kept as low as possible [11]. The most 
commonly used radiation therapy at present in Australia is external beam radiation therapy (EBRT) 
using megavoltage (MV) x-ray beams.  
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Less utilised are treatments using kilovoltage x-rays, electrons and radioactive sources. Proton 
therapy will be available in Australia in the near future [12]. It has been reported that currently in 
Australia the therapy utilisation rate for radiation therapy is approximately 48% [13]. 
Radiotherapy may be the primary treatment modality or may be used in conjunction with another 
therapy to: 
• destroy primary and metastatic solid tumours, 
• shrink a tumour prior to surgical excision,  
• destroy subclinical disease about a margin after a surgical excision, 
• treat subclinical disease along a known disease pathway. 
• salvage a treatment after a cancer recurrence. 
• boost tumour response when delivered concurrently with chemotherapy or another agent. 
• alleviate pain for a palliative patient by affecting rapid tumour response. 
Radiation therapy has a major impact on local cancer control and is highly effective treatment for 
control of cancer symptoms such as pain and bleeding [14]. 
2.4 Radiotherapy technology and technique 
To reduce normal tissue damage radiotherapy treatment delivers absorbed dose to the target tissue 
in parts known as fractions. A common fractionation regimen sees 2 Gy of absorbed dose delivered 
daily over the course of several weeks. The benefits of fractionation are: 
• Repair. By ensuring a minimum of 6 - 8hrs between fractions normal tissue is given adequate 
time to repair sub lethal damage (SLD).  
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• Redistribution. Fractionation ensures that cancer cells will be in a radiosensitive phase of the 
cell cycle for multiple fractions.  
• Reoxygenation. Oxygenation is important to assure high radiosensitivity. Rapid growing 
tumours can have inadequate vasculature causing hypoxic peripheral cells. Cell death 
inflicted by radiation increases supply of blood flow to these dormant (quiescent) cells [15]. 
The quality of fractionated treatment is quantified using the Therapeutic Ratio (TR). The TR is the 
ratio of tumour control to normal tissue complication for a treatment dose. Using past patient data, 
the probability of tumour control and normal tissue damage (toxicity) can be graphed for each site, 
treatment regimen and early/late tissue toxicity. Over a period of 5 -10 years fractionation regimens 
can be compared to determine optimal radiation therapies.    
 
Figure 2-2: Tumour control probability vs normal tissue damage probability [16]. 
In the last 20 years advancements in radiotherapy technology including 4D CT scanning, inverse 
planning, multi-leaf collimation and on-board imaging have greatly improved the utility and 
accuracy of treatment by linear accelerator.   
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As a consequence the therapeutic ratio for many treatment sites has increased [17]. With the 
introduction of the multi-leaf collimator (MLC) and inverse planning treatment planning software it 
became possible to deliver a standard dose with far greater conformity. The improved conformity 
saw a marked improvement in clinical outcomes with normal tissue toxicities greatly reduced. Later 
with more precise linear accelerators and the use of on-board imaging treatment volume margins 
were reduced and fraction doses substantially increased.  Stereotactic ablative body radiotherapy 
(SABR) or stereotactic body radiotherapy utilises dose escalation to deliver hypofractionation dose 
regimens.  High doses (≥ 8 Gy) per fraction are delivered in a small number of fractions.  
SABR has been demonstrated to achieve excellent local control rate for solid tumours with little 
metastatic disease. This treatment is considered most appropriate for sarcomas, colorectal cancer 
and germ cell tumours [18]. To ensure beams are delivered precisely radiotherapy clinics have 
introduced rigorous patient-specific quality assurance, high-performance machine credentialing as 
well as prescriptive treatment protocols that more greatly involve the radiation oncologist and the 
medical physicist.  
2.5 Radioprotectors  
While image guided patient positioning set up and VMAT dose delivery have improved the 
therapeutic ratio normal tissue toxicity remains a limiting factor in the treatment of many diseases 
using radiation therapy. The need to irradiate margins about a tumour and the proximity of critical 
structures to the treatment volume means normal tissue complication or toxicity must always be 
considered when deciding on a treatment option.  
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An alternative to reduce normal tissue toxicity is the use of radioprotectors, agents that when 
present prior to or shortly after radiation exposure alter the normal tissue response.  To be useful 
in the radiotherapy clinic radioprotectors should ideally have the following characteristics: 
• Selective. Protects normal tissue without protecting malignancy otherwise there will be no 
gain in the therapeutic ratio. 
• Easy to deliver and with minimal toxicity. If the agent is to be delivered safely and precisely 
in conjunction with radiotherapy, then biological uptake and clearance and toxicity must be 
well known. 
• Protects the RIGHT normal tissue. Prevents early or late toxicities that are dose limiting or 
significantly reduce the quality of life of the patient (i.e. mucositis, pneumonitis, myelopathy, 
xerostomia, proctitis and leukoencephalopathy). 
As described previously in section 2.2 free radicals are responsible for about 2/3 of the damage 
inflicted by megavoltage photon radiation. Therefore, for an agent to protect tissue against primary 
free radical damage, the agent needs to be present at the time of exposure and in sufficient 
concentration to compete with free radicals produced through photon-tissue interaction. 
Superoxide dismutase (SOD), catalase, glutathione peroxidase, and glutathione reductase are 
examples of naturally occurring antioxidants that mitigate free radical - mediate damage within the 
cell [19]. General antioxidant protection is also provided by low molecular weight antioxidants, such 
as ascorbic acid, tocopherols, polyphenols, and thiols such as glutathione. These compounds 
neutralise  oxidants by hydrogen atom donation [20]. Whereas radioprotectors need to have radical-
scavenging properties and can also exert general antioxidant activity, all antioxidants cannot afford 
radioprotection [21].  
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This determination may be a result of the relative reactivity of radiation-induced reactive species 
compared with those generated under conditions of general oxidative stress (i.e., H2O2 exposure). 
Scavenging hydroxyl radicals, such as those formed with radiation-induced damage, may be 
accomplished by almost any unsaturated organic molecule or molecule capable of H atom donation. 
Although hydroxyl radicals can be scavenged with equal efficiency by both radioprotectors and 
antioxidants, cellular and in vivo radioprotection is observed only with radioprotectors. This 
suggests that a secondary species is generated by hydroxyl radicals and is responsible for critical 
target (i.e., DNA) damage. This less reactive secondary species may not be scavenged by 
conventional antioxidants either because they do not accumulate in proximity to the secondary 
radical or they may not have kinetic reactivity to scavenge them effectively. Thus, thiols such as 
Amifostine [22] and nitroxides [23] have sufficient reactivity to efficiently scavenge secondary 
radicals. Conversely, well-known antioxidants such as vitamin C and vitamin E do not act as classic 
radioprotectors. 
 
For modern SABR a high dose fraction, small margins and delivery to a moving target leaves little 
room for error. In such cases a radioprotector drug or nanoparticle could be valued insurance 
against geometric miss. To date the only therapeutically approved radioprotector is Amifostine [24], 
[25]. Initially used to reduce toxicity of the chemotherapy drug, Cisplatin, it is now used to reduced 
moderate to severe xerostomia, mucositis and dysphagia in head and neck cancer patients. 
However, its broad clinical use has been stalled due to moderate/high side effects of nausea, emesis 
and hypertension in some patients [26].  
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2.6 Cerium oxide nanoparticles 
Cerium oxide is a lanthanide metal oxide crystal with a broad range of applications including use as 
an oxygen sensor [27], a catalytic converter [28], [29], a fuel cell [30], an anti-oxidant [31]–[33] and 
a radioprotector [31], [34], [35]. Its atomic structure is cubic fluorite with one Ce4+ ion surrounded 
by eight O2- ions to form the corner of a cube, with each O-2 ion co-ordinated to four Ce4+ ions as 
shown by the unit cell in Figure 2-3a. The unit cell is the smallest repeating unit of a crystal.   
 
Figure 2-3: The unit cell of cerium oxide exhibits a cubic fluorite structure (a) which can be distorted (b) by 
oxygen vacancies within the lattice [36]. 
The symmetric nature of the cerium oxide unit cell allows its physical dimensions (x, y, z) to be 
described by a single lattice parameter, a. The lattice parameter for bulk cerium oxide is 5.410 Å or 
0.5410 nm. The utility of the crystal is attributed to the ease at which cerium ions can switch 
between the 3+ and 4+ valence states at defect sites within the crystal. The oxidative switching is 
attributed to the similar energy of the 4f and 5d electronic states and the low potential barrier 
between them [37].  
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The oxygen vacancies that occur in at these defect sites allow easy passage of oxygen within the 
bulk material and the interaction of oxygen species about the surface of the crystal. When an oxygen 
vacancy occurs within the crystal a neighbouring cerium ion reduces to a 3+ valence state to affect 
electrostatic equilibrium. In the right conditions the redox potential of the cerium ions at the OVDs 
allow the facile cycling of valence states (3+4+3+) mentioned prior. 
Cerium oxide nanoparticles can be made from a number of different synthesis methods; co-
precipitation, spray-pyrolysis, hydrothermal [38] and sol-gel [39].   When cerium oxide nanoparticles 
are made small (< 20 nm) the strain within the lattice boosts the number of Ce3+ ions at the surface 
of the nanoparticle [40]. The efficacy of cerium oxide nanoparticles to work as a free radical 
scavenger has been shown to correlate with Ce3+ populations. While the exact pathways of 
reduction and oxidation are still under debate studies show that the scavenging is dependent on pH 
[41] and discriminates against tumour tissue owing to this pH dependence. Cerium oxide 
nanoparticles have been trialled in-vivo to mitigate normal tissue damage arising from the 
accumulation of free radicals. In one case Heckman et al. were able to penetrate the brain of mice 
with 3 nm cerium oxide NPs to reduce oxygen species levels and alleviate clinical symptoms and 
motor deficiencies in a murine model of multiple sclerosis.  In another instance nanoparticle were 
taken up in the retina of mice and mitigated oxidative stress linked to retina disease. In both cases 
there was prolonged uptake of nanoparticles with no identifiable toxicity.  
As a radioprotector, cerium oxide nanoparticles have been tested on a number of irradiated cell 
lines demonstrating an ability to mimic other antioxidant macromolecules like super oxide 
dismutase and catalase to reduce normal tissue reaction.  
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More recently cerium oxide particles have been demonstrated through in-vivo experiments to 
decrease xerostomia and dermatitis in head and neck irradiation [42] and protect epithelial tissue 
in the lung and gut by scavenging free radicals and increasing the cellular concentration of SOD2 
[43], [44].  
Current work on cerium nanoparticles looks to optimise colloidal stability, uptake and serum 
clearance through to tissues and organs. It’s widely believed that these outcomes are best achieved 
through the use of biocompatible coatings such as folic acid or acetate/EDTA.  While most results 
to date have been promising there are some reports of toxicity that must be further investigated 
and work is now underway to better understand the internalisation and subcellular localisation of 
cerium oxide nanoparticles within individual cell types [45]. 
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Chapter 3  
METHODS and MATERIALS 
3.1 Cerium oxide particle synthesis 
Cerium oxide particles were synthesised and characterised at the Institute of Superconducting and 
Electronic Materials (ISEM), University of Wollongong under the supervision of Associate Professor 
Konstantin Konstantinov and the assistance of postgraduate students Dean Cardillo and Kathrin 
Bogusz. Two methods of synthesis were used to produce cerium oxide and iron (Fe3+) doped cerium 
oxide particles. The first method chosen was co-precipitation, however due to later complications 
it was succeeded by spray pyrolysis. Iron (III) was chosen instead of samarium to dope particles as it 
was readily available and also trivalent. It was reasoned it should effectively suppress Ce3+ formation 
through lattice inclusion.    
3.1.1 Synthesis by co-precipitation 
Co-precipitation of cerium oxide particles, pure and doped, was achieved using cerium (III) nitrate 
hexahydrate Ce(NO3)3.6H2O (Sigma > 99%), iron  (III)  nitrate nonahydrate Fe(NO3)3.9H2O (Sigma 
> 99%) and anhydrous sodium hydroxide NaOH (Sigma > 99%). 8.68 g of Ce(NO3)3.6H2O (0.02 moles) 
and 2.81 g of NaOH (0.07 moles) were added to separate beakers containing 100 ml of deionised 
water. Under magnetic stirring the Ce(NO3)3 solution was added drop wise to NaOH at a rate of 
5 ml/min. The resulting purple suspension was centrifuged (Eppendorf, Centrifuge 5702) at 
1100 rpm for 10 minutes. The solution was decanted and the resulting purple precipitate muddled 
with glass rod and deionised water to produce a suspension. Centrifuge and wash was repeated 
twice with a final centrifuge.  
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The precipitate was dried at 60 ⁰C for 12 hours becoming a grainy powder of cerium oxide particles. 
A portion of powder was placed in a ceramic crucible and heated in a tube furnace for 6 hours at 
300 ⁰C with the intent of dehydrating, purifying and crystallising. The synthesis of the iron doped 
cerium oxide particles occurred similarly except moles of Fe3+ ions were substituted for moles of 
Ce3+ ions to achieve the successive atomic doping of 5 %, 10 % and 20 % iron as shown in Table 3-1. 
Cerium Oxide Particles    Reagents dissolved in DI water  
Pure    0.02 moles Ce3+ + 0.07 moles NaOH 
5 % Fe    0.019 moles Ce3+ + 0.001 moles Fe3+ + 0.07 moles NaOH  
10 % Fe   0.018 moles Ce3+ + 0.002 moles Fe3+ + 0.07 moles NaOH 
20 % Fe   0.016 moles Ce3+ + 0.004 moles Fe3+ + 0.07 moles NaOH 
 
Table 3-1: Reagent quantities for synthesis of nanocrystalline cerium oxide particles by co-precipitation 
 
3.1.2 Synthesis by spray pyrolysis 
The second synthesis method of spray pyrolysis did not require NaOH to form cerium oxide particles, 
however to reduce environmental contamination nitrate quantities had to be increased by a factor 
of 10. For cerium oxide particles 450 ml of 0.5 M cerium (III) nitrate solution was sprayed, via a 
peristaltic pump, through a nitrogen pressured aerosol head at a rate of 300 ml/hr into a tube 
furnace standing vertically at ~3 m tall. The heat of the furnace rapidly reacted the cerium  (III)  nitrate 
solution with air to form spherical cerium oxide particles [46]. The particles fell to the base of the 
furnace and were forced by air into a catcher bin.  
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After 100 ml of the cerium  (III) nitrate solution had been sprayed the delivery system was stopped 
and the catcher bin cleaned and emptied. The cerium oxide particles removed were kept but not 
used as to avoid contamination from previous material works. The system was restarted and the 
remainder of the viable cerium oxide particles were collected. This process was repeated for all iron 
doped particles. Again, as was the case previously iron doping was achieved through molar 
substitution of Ce3+ for Fe3+ ions. It took approximately two days to produce the pure cerium oxide 
and the 5 %, 10 % and 20 % iron doped cerium oxide powders. Quantities of all reagents used in 
synthesis can be found in Table 3-2. 
 
Cerium Oxide Particles    Reagents dissolved in DI water  
Pure    0.2 moles Ce3+  
5 % Fe    0.19 moles Ce3+ + 0.01 moles Fe3+  
10 % Fe    0.18 moles Ce3+ + 0.02 moles Fe3+  
20 % Fe   0.16 moles Ce3+ + 0.04 moles Fe3+  
 
Table 3-2: Reagent quantities for synthesis of nanocrystalline cerium oxide particles  
 
3.2 Particle characterisation 
3.2.1 X-ray diffraction 
Crystal structure analysis was performed on all particles, co-precipitate and spray pyrolysis, using a 
GBC Mini Materials Analyser (MMA) X-ray Diffractometer. Mortar and pestle and 100 % ethanol was 
used to break up particles and produce a slurry. This slurry was applied to a quartz plate evenly ad 
after evaporation produce a thin mono-layer as show in Figure 3-1.  
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The mono-layer was irradiated with a monochromatic, copper Kα x-ray beam (λ = 1.5406 Å) from 20 
- 90 ⁰ with a step size of 0.02 ⁰ and a speed of 2 ⁰/min. Traces software was used to identify the 
nature of the phase. The Scherer formula below was applied to the most intense 3 peaks, which 
were fitted using a Gaussian function, to determine the mean crystallite size:  
 
Equation 3-1             
                                                            
𝑇𝑐 =
𝑘𝜆
𝐵.𝑐𝑜𝑠𝜃            
where B = Bobs - Bstd                      
 
where CT   is the mean crystallite size, k is a constant shape factor for cubic crystals set at 0.85, λ is 
the measuring x-ray wavelength, Bobs is the observed full width half maximum (FWHM) of the 
measured peak, Bstd is the instrumental contribution and θ is the diffracting angle of the chosen 
peak. Unit cell parameters and phase composition were investigated using Rietveld refinement 
(MAUD software) utilising bulk phase files for cerium oxide (#01-089-8436 from ICSD) and haematite 
(#13-0534 from JCPDS). 
 
 
Figure 3-1: XRD prepared slurries for pure (right) and 5% iron doped (left) cerium oxide particles. 
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3.2.2 Thermal gravimetric analysis 
Thermo-gravimetric analysis (TGA) using the Metter Toledo TGA/DSC STAResystem was used to 
determine the optimum annealing temperature. 100 mg of particles were placed in an aluminium 
oxide crucible. The crucible and a standard crucible were placed in an argon atmosphere and heated 
from 60 ⁰C to 1000 ⁰C at a rate of 10 ⁰C/min. The weight of both the standard and sample crucible 
was tracked to determine an approximate annealing temperature. Purity was assessed as a function 
of percentage weight loss. When weight loss ceased the sample was considered pure and the 
heating temperature noted as an approximate of the optimum annealing temperature.  The 
maximum heating temperature was well below the melting and boiling point of cerium oxide lattice 
being 2,400 ⁰C and 3,500 ⁰C respectively.  
The temperature derived from this process would be higher than optimal due to the lag of thermal 
equilibrium; it takes time for heat to propagate throughout the material. The optimum annealing 
temperature determined by heating the particle powders at progressively hotter to find the 
minimum temperature at which weight loss plateaued. 
3.2.3 Optical emission spectroscopy 
The atomic concentration of cerium and iron ions within pure and doped cerium oxide particles was 
assessed using inductively coupled plasma - optical emission spectrophotometer (ICP-OES). The ICP-
OES used at ISEM is the Vista MPX by Aligent.  Standards solutions were fed into an argon torch 
where ions of interest omitted characteristic light. Standards curves were constructed to calibrate 
light intensity to concentration of ions of interest. 1000 ppm standard solutions for cerium and iron 
were purchased from Aligent. Using serial dilution standard curves were produced ranging from 0 - 
120 ppm. These curves were used to convert light output for sample solutions into constituent 
atomic concentrations.  
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To overcome strong covalent bonding of the ceramic particles sample solutions were prepared using 
50 % hydrogen peroxide H2O2 (Sigma) and 35 % nitric acid HNO3 (Sigma). To dissolve the pure cerium 
oxide particles 5mg of particle powder was added to 5 ml of nitric acid and lightly stirred at 60 ⁰C in 
a fume hood. Hydrogen peroxide was then added drop wise until the suspension turned clear (3-5 
drops), giving approximately 500 ppm cerium solution. 1 ml of the cerium solution was pipeted into 
a 10 ml volumetric flask and 9 ml of 18 MΩ deionised water added to make a 50 ppm solution. This 
digestion process was repeated for all particle powders.   
3.2.4 Transmission electron microscopy 
Images of the particles were acquired to investigate crystallite size and particle size. Transmitted 
electron detector (TED) images were taken using a JSM-7500FA cold Field Emission Gun Scanning 
Electron Microscope (JEOL, Japan). The microscope was operated at an accelerating voltage of 17-
25 kV at a working distance of 8 mm and a beam current of 10 µA with a spot size setting of 8. 
Particles were sonicated in 100 % ethanol at a concentration of 1000 µg/ml. The resulting suspension 
was pipeted on to carbon film coated copper grids and left to dry.   
3.2.5 X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy was utilised to determine the populating ratio of Ce3+/Ce4+ ions 
within the pure and iron doped cerium oxide particles. The analyser was installed in a high vacuum 
chamber with a base pressure below 8-10 millibars. X-ray excitation was provided by aluminium Kα 
photons with energy of 1486.6 eV at a voltage of 12 kV and a power of 120 W. The spectra were 
collected at a pass energy of 20 eV in a fixed transmission mode. The spectra were calibrated using 
the C1s carbon binding energy peak found at 284.8 eV.  
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The peak represents the C-C bond found in adventitious carbon; a common contaminate introduced 
via the atmosphere during sample preparation. Peak binding energy parameters for the cerium 
binding spectra were collected from the N.I.S.T photoelectron spectroscopy database [47] and are 
shown in Table 3-3. The data was used to deconvolve the 11 orbital peaks found in cerium oxide 
NPs as a result of oxygen defects. 
Peak Ion Intensity 
(a.u) 






Std 916.7 3d3/2 
B Std 907.3 3d3/2 
C Std 900.8 3d3/2 
D A*1.5 898.3 3d5/2 
E B*1.5 888.6 3d5/2 
F C*1.5 882.3 3d5/2 
G 
Ce3+ 
Std 903.7 3d3/2 
H H*0.85 899.1 3d3/2 
I Std 855.4 3d3/2 
J I*0.85 855.4 3d3/2 
 
Table 3-3: Binding energy peak data for cerium oxide retrieved from N.I.S.T XPS database.  
 
3.3  Cerium oxide particle storage and preparation 
3.3.1 Storage 
As a precaution, it is suggested anyone handling the particles use nitrile gloves and a micron gauge facemask in 
a well-ventilated area. Pure cerium oxide particles were found to be extremely hygroscopic. Particle 
powder (16 - 20 g) was kept in a 10 L vacuum desiccator at ISEM, Innovation campus. Working stock 
used entirely at IHMRI was kept in autosampler vials buried in 3 mm silicon dioxide beads (Sigma 
Aldrich) held within a small plastic container (Figure 3-2).  
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This allowed the particles to be moved about IHMRI easily. All particles were handled using a small 
trough spatula and gloves. Weighing of particles was done in a still space to prevent powder being 
blown away. To extract the particles, the autosampler vial was rotated while dragging the spatula 
through the top layer of the powder. When there was sufficient material the spatula was pressed 
against the side of the vial to compress the powder. The pressing further reduced particle loss.   
 
Figure 3-2: Portable desiccator for transport of cerium oxide nanocrystalline particles 
 
3.3.2 Weighing and sterilising 
The particles were weighed using the precision balance (KERN, ALS 220-4N). Prior to weighing the 
balance was levelled using the inbuilt spirit level. A mount was fixed by adhesive plasticine to the 
centre of the balance to ensure the sample tube (Falcon 15 ml, Sigma Aldrich) stayed upright when 
particles are being weighed. The uncapped tube was placed in the balance, all doors closed and the 
tube given time to settle. The tube weight was tared. The tube was carefully removed from the 
balance and 3-4 mg of particles placed swiftly at the bottom of the tube and the tube given a quick 
tap with the spatula.  
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It's important all particles get to the bottom of the tube to avoid weighing error. The tube was 
returned to the balance, all doors again closed and the particle powder weight recorded. Ideally 
particles should be placed in the falcon tube just once. It takes a little practice to be able to visually 
determine the weight of the particles; especially as density changes significantly between pure and 
doped cerium oxide powders. Particles were then sterilised using an autoclave on dry cycle at 121 ⁰C 
for 15 minutes at 2 bars of pressure. Before sterilising tubes were places in a 500 ml beaker and their 
lids screwed open to allow for pressure equalisation during the drying phase. The lids were 
tightened immediately after the end of the cycle to prevent contamination. 
3.3.3 Nanoparticle formation using sonication 
Sonication was essential for the cellular activity of cerium oxide particles as micron size 
nanocrystalline CeOx spheres were broken down to nano size fragments. Inside the BSC falcon tubes 
containing particles were filled with warm (37 ⁰C) DPBS (- -) to produce 1000 µg/ml particle 
suspensions. The warm DPBS helped to keep cerium oxide particles dispersed during initial 
sonication. Capped falcon tubes were placed in the tube holder (orange) and fixed to sonication 
bath (Branson 3800) as shown in Figure 3-3. The bath was filled with tap water until the surface of 
all particle suspensions sat below the surface of the water fill. Suspensions were sonicated for 2 
hours. Every 20 minutes suspensions were removed from the bath, shaken vigorously for 10 seconds 
and rotated clockwise to the next position to ensure consistent sonication.  
When sonication was successful the suspensions became 'milky' and particles stay suspended for a 
minute or more (Figure 3-4). The density of the materials, while not quantified, is significantly higher 
than water. Coupled with an agglomerate size of at least 50nm in a single dimension means 
eventually all materials will gravitate to the bottom of the flask to form sediment.  
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Figure 3-3: Sonication of cerium and iron doped particle suspensions in PBS (- -). In later setup tube positions 
were spread evenly about the bath and tubes rotated though positions during sonication to optimise fracturing. 
 
 
Figure 3-4: Suspensions of cerium oxide nanoparticles at 1000 µg/ml in PBS (- -) formed through sonication. 
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3.4 Biological assessment  
Cell growth and radioprotection studies of cerium oxide nanoparticles were performed by 
clonogenic assay at the Illawarra Health Medical Institute (IHMRI) under the supervision of Dr 
Moeava Tehei.  The 9L gliosarcoma cell line (ECCC, Salisbury, Wiltshire, UK) was chosen for all cell 
line studies. Although a cancer analog, previous work by Briggs (2013) had shown the 9L cell line to 
be selective to radioprotection by pure CeOx NPs undergoing megavoltage radiation exposure [48]. 
The doubling time of the cell line was approximately 36 hrs.  
3.4.1 Cell culture reagents and consumables 
A range of media, supplements and stains were required to maintain cell viability and assess the 
effects of particle inclusion. Materials used specifically for health and maintenance of the cell line 
were Dulbecco's Modified Eagle Media (DMEM), Fetal Bovine Serum (FBS), Penicillin-Streptomycin 
(Pen Strep), Dulbecco's Phosphate Buffered Saline (DPBS) and Trypsin EDTA. The DPBS came in two 
variants, with inclusion of calcium and magnesium labelled "+ +" and the omission of these ions 
labelled "- -". Calcium and magnesium ions promote cell adherence. All biological materials were 
handled in a class 2 Biological Safety Cabinet (BSC) and additives and equipment to be used within 
were sterilised by autoclave and/or ethanol spray before use.  
3.4.2 Preparation of cell culture medium 
DMEM is supplemented using 10 % FBS and 1 % Pen Strep to boost cell growth and fight infection. 
Fully supplemented DMEM is labelled c-DMEM for 'complete' media. To assess viability of the 
completed media 3 aliquots of 1 ml volume were drawn into 1.5 ml Eppendorf tubes and incubated 
at 37 ⁰C in 5 % (v/v) carbon dioxide atmosphere. Three days later the aliquots were assessed for 
microbial intrusion.  
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The chosen DMEM contains a pH indicator of phenyl red and is pH buffered through the inclusion 
of 3.7 g/L of sodium bicarbonate. The media is buffered for 10 % (v/v) CO2 environment resulting in 
a slightly basic media when incubated at 5 % (v/v) carbon dioxide. Cell proliferation and the resulted 
output of carbon dioxide will reduce media pH towards neutral. The colour of the media is a helpful 
tool for quickly assessing cellular activity and in this case microbial intrusion as shown in Figure 3-5.  
 
Figure 3-5: Phenyl Red as a pH indicator in DMEM cell line media. 
3.4.3 Passaging (subculture) of cell line 
 Cells were grown as a monolayer in a T75 flask (75 cm2), containing c-DMEM until they reach 90 % 
confluence. Cells were then passaged to a new flask to prevent cell degradation and change to 
morphology. Passaging occurred inside the BSC. Media was removed by pipet from the T75 flask 
and the monolayer washed with DPBS (- -) to remove cellular debris and possible contaminates. 2-
3 ml of trypsin was then carefully added and the flask incubated for 3-7 minutes.  
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The purpose of trypsin is to detach the cells by dissolving surface protein anchors.  Upon removal 
from the incubator the flask was gently tapped to remove attached cells. Media was observed at 
10 X magnification to verify detachment using a low powered inverting microscope (Olympus, KX 
series, 4 - 40X magnification). 8 ml of c-DMEM was added to the flask and the cell suspension was 
drawn and flushed 10 times, slowly, taking care not to aerate the media too greatly. The cell 
suspension was again viewed under the microscope to confirm all cells were separated and intact. 
0.1 ml of cell suspension was then aliquoted into an Eppendorf tube and from this 10 µL was pipeted 
to a mixing palette and diluted at a range of 1:5 to 1:7 using Trypan Blue dye. 
 
Figure 3-6: Counting viable cells using a haemocytometer [49]. 
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The dye has two roles. It serves as a dispersant to spread cells evenly on the counting grid of the 
haemocytometer (Brand, Germany) so they don’t overlap. Secondly, the diazo dye selectively 
penetrates the membrane of dead cells. When viewed under the inverting microscope at 20 X 
magnification the viable cells contrast well against the Trypan Blue background. The full grid on the 
haemocytometer contains nine squares, each of 1 mm2 area and a depth of 0.1mm containing a 
volume of 100 nl. Cells are counted in 5 of these squares (marked red in Figure 3-6) to determine an 
average amount of cells per square. To ensure an accurate count cells on the left and bottom 
perimeter of each square are excluded. The cell concentration of the cell suspension in the T75 flask 
is then determined using the following formula:        
Equation 3-2                                                     cells/ml = average cells per square * dilution factor * 104                                         
The cell concentration and Table 3-4 were then used to determine the cell suspension volume 
required for seeding. The cell suspension was transferred from the old T75 flask to new T75 flask 
containing 20 ml of fresh c-DMEM. Details of the cell type, user, passage number and date were 
written on the flask using indelible pen.  The seeding populations in Table 3-4 have been determined 
experimentally and average over a wide range of passages (30 - 60). To ensure the health of the cell 
line doubling times were continually verified throughout the lifetime of the cell line. 
 










T12.5 12.5 1,200,000 300,000 200,000 120,000 
T75 75 10,000,000 2,500,000 1,500,000 - 
 
Table 3-4: Seeding population for 9L cells was determined through several lifetimes of the cell.  
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3.4.4 Clonogenic survival assay 
In a clonogenic assay a cell’s survival is correlated to a minimum size colony grown on the surface 
of a plating dish. The gold standard for this type of assessment is colonies of 50 cells or more grown 
for approximately 14 doubling times [50]. For the purpose of biological assessment, a cell is deemed 
dead when it can no longer proliferate. A surviving cell that can proliferate indefinitely is known as 
a clonogen. 
9L clonogenic assays were perform on the pure and iron doped cerium oxide nanoparticles using 
T12.5 flask and BD 100 mm Primaria culture plates. The Primaria plates have a heat-treated surface 
that improves cell adherence. The seeding of culture plates is known as plating. 5 days prior to 
plating 120,000 cells were transferred to each T12.5 flask containing 5 ml of c-DMEM to achieve a 
surface cell density of 9,600 cells/cm2. This density of cells achieved a 90 % confluence at the time 
of plating.  
1 day prior to plating particles were weighed, sterilised, sonicated and included in flasks. 250 µL of 
1000  ug/ml nanoparticle solution was added to required T12.5 flasks to achieve a particle 
concentration of 50  ug/ml. Flasks were then stored in incubator at 37 ⁰C in 5 % (v/v) CO2 
environment. Before plating occurred, equipment was sterilised and set up as shown in Figure 3-7. 
Once all equipment and materials had been included in the BSC, plates were labelled and filled with 
10 ml of c-DMEM. Flasks were processed two at a time. For each flask media was removed and the 
cell monolayer washed with DPBS (- -). The layer was trypsinated and incubated to detach and 
separate the cell layer from the flask surface. 
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Figure 3-7: Preparation for 9L cell plating within the BSC requires the prefilling of many 100 mm plating dishes.  
During incubation, a 50 ml conical tube was filled with 2.1 ml of c-DMEM. The flask was removed 
from the incubator and lightly tapped with cells being viewed at magnification to ensure they were 
not clustered or attached. 1 ml of c-DMEM was then added to the T12.5 flask and the cell suspension 
and fresh media drawn and flushed 20 times to separate cells. While separation is essential for 
clonogenic assays care should be taken not to overly aerate the media as too much oxygen can kill 
the cells.  0.3 ml of mixed cell suspension was drawn from the T12.5 flask and passed to the falcon 
tube to form a 1:8 diluted cell suspension. To ensure homogeneity the cell suspension was drawn 
and flushed 10 times. The conical tube was then centrifuged at 1200 rpm for 3 seconds and two 
10 µL portions were micro-pipeted to the haemocytometer.  
Equation 3-2 was used to determine the required seeding volumes for plating. Plates were moved 
back and forth in a consistent fashion to disperse cells evenly. When this process was completed for 
both flasks all plates were stacked and moved to the incubator. Plates were triplicated at seed 
counts of N, 2N and 4N to minimise sampling error and safe guard against fluctuations in cell growth 
(factors: adherence, doubling time, apoptosis, etc.). Plates were incubated for 21 days (approx. 14 
doubling events) and afterwards colonies were fixed and stained for subsequent quantification.  
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Optimised cell seeding, based on inclusion effects should result in growth of 100 - 150 colonies. 
Below 100 colonies and the plate data start to become unreliable. Plates were first removed from 
the incubator and media was removed by pipet.  Plates were washed twice with DPBS (+ +) to 
improve cell adherence. 1 ml of 75 % ethanol: 25 % crystal violet solution was added to each plate 
for a couple of minutes to stain and fix the colonies (Figure 3-8). The plates were rinsed with tap 
water until no residual crystal violet could be seen and left to dry for a few days. Crystal violet is 
considered a carcinogen and at the end of its use it was collected into a plastic jerry can for later 
disposal as a hazardous waste.  
 
Figure 3-8: Stained colonies fixed with crystal violet. 
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Once dry plates were counted blind to determine the number of viable colonies present. Any colony 
containing 50 or more cells of a normal shape is considered viable. As some colonies can be quite 
small a stereoscopic microscope must be used periodically to verify colony sizes. Colony counts were 
then used to determine plating efficiency.  
Equation 3-3                      Plating efficiency (PE) = no. of viable colonies / no. of seed cells 
 
Plating efficiencies for cell line series 9L + NPs were then normalised against the 9L control line series 
to determine survival/growth fractions. 
 
3.4.5 Radiation delivery 
Prior to irradiation at Prince of Wales hospital 9L cells were prepared as described in section 3.4.4. 
In addition, all T12.5 flasks were filled to the brim with HBSS with phenyl red inside the BSC. This 
was done to provide enough depth of build-up to ensure an accurate absorbed dose was delivered 
to the monolayer of cells. To ensure no contamination to the hospital environment all flask caps 
were wrapped with para-film and secured in a biohazard carry case for transportation to and from 
the hospital.  
Cells were irradiated with the assistance of Deputy Director of Radiation Oncology Medical Physics, 
Dr Stephanie Corde. 10MV x-ray irradiation of cells was performed using an ELEKTA Versa HD linear 
accelerator (Figure 3-9). Four flasks at a time were placed on 10 cm of solid water (Model 457, 
Gammex) and secured with Superflab and solid water offcuts. The SSD was set to 100 cm and 
radiation was delivered using a 15 cm square field at a dose rate of approximately 500 Gy/min at the 
cell mono-layer. 
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Figure 3-9: Flasks set for delivery of dose using the ELEKTA Versa HD linac.  
To ensure accurate cell survival curves flasks were dosed to 1 Gy, 2 Gy, 3 Gy, 5 Gy and 8 Gy. In total 
seven flasks, including two control flasks were irradiated to obtain a single curve: 
• 9L cells 
• 9L cells + pure CeOx NPs 
• 9L cells + 5% Fe doped CeOx NPs 
• 9L cells + 10% Fe doped CeOx NPs 
Upon return to IHMRI facilities flasks were immediately plated as described in section 3.4.4. Control 
flasks were plated first and last to mitigate cell growth during plating. Cells were again incubated 
for 21 days for a later stain and fix of grown colonies.   
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3.4.6 Cell survival curves 
A survival curve describes the relationship between the radiation dose and the fraction of cells that 
survive. Survival curves for mammalian cells are normal presented with dose plotted linear on the 
horizontal axis and survival fraction plotted logarithmically on the vertical axis. They are an effective 
mechanism for characterising mammalian cell lines, comparing the effectiveness of different 
radiation therapies and concurrent drug schemes.  
 
Figure 3-10: Survival curve for low LET photons. (Adapted from Hall 2012) 
The intention in this study was to use survival curves to assess the impact of Ce3+ ion population on 
radioprotection afforded to the 9L cell line. The standard of comparison between curves was the 
Performance Enhancement Ratio (PER).  The PER is the ratio of doses delivered for a common 
biological end point. In this instance 10% survival fraction (Equation 3-4). 
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Equation 3-4                                                 𝑃𝐸𝑅 =  (
𝐷𝑜𝑠𝑒 𝑑𝑒𝑙𝑖𝑣𝑒𝑟𝑒𝑑 𝑡𝑜  9𝐿+𝑁𝑃 





Equation 3-5               𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (𝑆) = exp (−𝛼𝐷 − 𝛽𝐷2)     
 
The model of cell survival used in this study was the linear-quadratic model. It assumes two 
components to cell killing. One component, α is proportional to dose, D (a single hit kill) and the 
other, β the square of the dose (a double hit kill). By the fitting Equation 3-5 to each curve the 
radiosensitivity for each cell line series could be quantified as an alpha-beta ratio. This ratio can be 
used to characterise the radiosensitivity of the cell and better understand NP influence during 
radiation exposure. Generally, a radioresistant tissue would have a low α/β of 1-4 and a 
radiosensitive tissue would have a value much closer to 10.  
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Chapter 4  
Results and Discussion 
4.1 Cerium oxide particles by co-precipitation 
4.1.1 Synthesis 
 
Figure 4-1: Cerium oxide powders formed by co-precipitation: pure, 5% iron and 10% iron doped and annealed 
at 550 °C 
Producing small (< 10nm) nanocrystalline cerium oxide particles by co-precipitation proved 
problematic. The main obstacle faced was the lack of detail in many methods published; 
temperature of solution, gestation time, concentration of oxidiser, etc. The chemical pathway of 
cerium oxide crystallisation can be ideally described by the following net chemical reactions:  
Equation 4-1                                                                                                      𝐶𝑒3+ + 3𝑂𝐻− → 𝐶𝑒(𝑂𝐻)3                                                                                                  
Equation 4-2                                                                               2𝐶𝑒(𝑂𝐻)3 + 𝑂2 → 2𝐶𝑒(𝑂𝐻)4                                                                                               
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Equation 4-3                                                                                             𝐶𝑒(𝑂𝐻)4 → 2𝐻2𝑂 + 𝐶𝑒𝑂2                                                                                            
Driven by strong basic conditions, pH=8, cerium nitrate reacted quickly to form a purple precipitate 
of cerium (III) hydroxide (Equation 4-1). The precipitate was muddled and washed to remove sodium 
and nitrates. An adverse effect of this process was the formation of a small portion of cerium nitrate, 
seen as a thin layer of white at the bottom of centrifuged mass. The precipitate was dried at 60 ⁰C 
for 24 hours. Within a few hours of drying the precipitate had started to turn orange/ yellow as it 
oxidised (Equation 4-2) and crystallised, through dehydration (Equation 4-3). After 24 hours, the 
resultant product was a grainy yellow powder of cerium oxide nanocrystalline particles. In the case 
of the doped production more iron in the starting solution resulted in browner precipitates and 
browner cerium particles. The increasing depth of colour was an indication the doping process had 
been successful. (Figure 4-1) 
4.1.2 Annealing 
Nitrates are considered toxic to mammalian cells [51] and while small crystals were essential for the 
radioprotection efficacy of cerium oxide nanoparticles it could not be at the expense of purity. 
Annealing the particles thermally decomposed nitrates and drove further crystallisation. TGA was 
used as an expedient method of determining the lowest possible annealing temperature required 
to achieve purity within particle powder. After accounting for thermal equilibrium lag that 
temperature was determined to be approximately 700 ⁰C for both cerium oxide particles and 10 % 
iron doped cerium particles (Figure 4-2), Weight loss of cerium oxide powder to the 10 % iron doped 
powder was 9 % to 7 % respectively. The larger weight loss of the pure particles is attributed to 
greater moisture content. Throughout experiments cerium oxide powder was found to be 
significantly more hygroscopic than its iron doped variants. 
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Figure 4-2: Ramp heating particles to determine gross annealing temperature of pure cerium oxide and 10 % iron 
doped particles 
 
Figure 4-3: Step heating to determine precise annealing temperature for pure cerium oxide particles for 
controlled annealing of all particles. 
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Looking to Figure 4-2 the initial decay of mass in both mass curves (<250 ⁰C) can be primarily 
attributed to water loss and the final decay (> 400 ⁰C) largely to the crystallisation of amorphous 
cerium oxide and exotics CeOOH through dehydration. The intermediate decay curve (250 - 400 ⁰C) 
of the iron doped mass curve can be attributed to thermal decomposition of iron nitrates and the 
crystallisation of amorphous iron oxide and exotics FeOOH [52]. The lowest temperature required 
to stabilise mass loss was found to be 550 ⁰C (Figure 4-3). 
 
4.1.3 Characterisation  
 
When initially deciding on an annealing temperature TGA had not been available so it was decided 
to attempt a range of temperatures with the express purpose of producing a pure and small crystal. 
While a small crystal size was achieved at low heat it was later acknowledge that possible 
contamination by adventitious carbon would require annealing temperatures in excess of 500 ⁰C to 
achieve the required purity. After TGA the required annealing temperature to was confirm to be 
550 ⁰C. XRD analysis determined all particles to be of a single cubic fluorite phase with the reflection 
pattern identified as that of cerium oxide.  
XRD analysis of all annealed particles is presented in Table 4-1. For ease of analysis XRD patterns are 
displayed only for those particles annealed at 550 ⁰C (Figure 4-5). The trending shown in these XRD 
patterns are similar for all three annealing sets; 60 ⁰C, 300 ⁰C and 550 ⁰C.  While a bulk cerium oxide 
crystal would display discrete peaks at each reflection angle the peaks of the cerium oxide particles 
were much broader suggesting small crystallite size. The Scherrer formula determined constituent 
crystal sizes for each particle to range between 3 nm and 15 nm.  
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Particle    Atomic composition by EDX  
   Ce (%)                 Fe (%)                   Na (%) 




   95 ± 2.0 
 
0.0 ± 0.0 
 
5.0 ± 2.0 
60 3 – 4 5.436 
300 5 – 6 5.428 




   91.8 ± 0.6 
 
3.0 ± 0.2 
 
5.2 ± 0.6 
60 5 – 6 5.424 
300 6 – 7 5.419 




   86.0 ± 4.0 
 
7.7 ± 0.1 
 
6.0 ± 4.0 
60 6 – 7 5.417 
300 6 – 7 5.408 
550 8 – 9 5.399 
 
20 % Fe 
 
   79.0 ± 4.0 
 
17.0 ± 1.0 
 
3.0 ± 3.0 
60 4 - 5  5.414 
300 4 – 6 5.393 
550 6 – 8 5.393 
 
Figure 4-4: Structure, composition and size of pure and iron doped cerium oxide particles.  
 
Figure 4-5: XRD reflection patterns for pure (a), 5% Fe doped (b), 10% Fe doped (c) and 20% Fe doped (d) cerium 
oxide particles synthesised by co-precipitate and annealed at 550 °C. 
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Some general trends in size and structure were: 
• all crystals were of cubic-fluorite arrangement. 
• crystal size increased with annealing temperature for each compositional variant 
• the lattice parameter, a, reduced with increased crystal size. 
• increasing the atomic concentration of iron reduced the lattice parameter, a  
As expected, increasing the heat flow to precursor material increased the growth of the individual 
crystal while the lattice parameter shortened with crystallite size.  The lattice parameter shortening 
is attributed to a decreasing population of Ce3+ ions in a crystal and is further investigated in section 
4.1.4. For iron doped cerium oxide particles, the absence of detectable haematite (α-Fe2O3) or 
maghemite (γ-Fe2O3) peaks in all XRD patterns suggests that most included iron is substitutionally 
included. It's possible the 20 % iron doped particles are covered with small amounts of interstitial 
iron oxide as a result of surpassing the solubility limit of the cerium oxide crystal [53]. The 
introduction of Fe3+ ions within the cerium oxide crystal lattice should have reduced the distance*, 
d  between adjacent lattice planes and consequently the cell parameter, as the ionic radius of Fe3+ 
is 0.78 Å compared to 0.97 Å for Ce4+ ions and 1.14 Å for Ce3+ ions [54]. Bragg's law dictates a 
reduction in d will result in an increased to the scatter angle, θ.  
Equation 4-4                                                                                                                     𝒏 𝝀 = 𝟐𝒅𝒔𝒊𝒏𝜽    𝒏 = 𝟏 ⁄                                                                                                    
Analysis of Figure 4-5 confirms this shift of reflection peaks; being most prominent at the large angle 
reflection planes of 4,2,0 and 4,2,2. As expected the shift is greatest for the most heavily doped 
cerium oxide particles. The reduction of the lattice parameter, a, was confirmed through Rietveld 
refinement on individual XRD spectra.  
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In the case of the 550 ⁰C annealing set the lattice parameter for the pure particle was found to be 
5.416 Å with increasing iron doping reducing it to a minimum of 5.393 Å. It should be noted that the 
lattice parameter for bulk cerium oxide crystal is 5.410Å. The reduction in the d-space could 
potentially reduce crystal strain and subsequently reduce dynamic oxygen vacancies; increasing the 
lattice parameter. Alternatively, the opposite could be true; Fe3+ ions inhibit cerium oxide crystal 
growth and increase oxygen vacancies.  
All that can be said at this stage is the lattice parameter is being affected by the inclusion of iron 
and any increase in oxygen vacancies due to diminished particle size is being masked by reduction 
in d-spacing within the cerium oxide crystal lattice.  
EDS analysis of the composition of the cerium oxide particles determined sodium contamination at 
approximately 5 % atomic concentration. (Table 4-1) While sodium is essential component for 
mammalian metabolism [55] it's inclusion in this case could alter cell behaviour and affect the 
surface chemistry of the cerium oxide particles. As well the sodium displacement of cerium and iron 
affected the target atomic composition. Finally, the size of the 550⁰C annealing set was large at 
~14 nm meaning the radioprotection efficacy of the particles could not be assured. It was decided 
to synthesis the nanoparticles by flame spray pyrolysis instead. 
* The notation d l,m,n is used to denote the distance between adjacent lattice planes with the integers l, m, n 
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4.1.4 Oxygen Vacancies Defects (OVD) 
The need to produce three annealing sets of particles provided the opportunity to investigate the 
lattice parameter dependency on particle size for the pure cerium oxide particles. Past studies had 
shown an exponential increase in the lattice parameter as particles became small (3-10 nm) [21]. 
This rapid increase was explained by an increasing population of Ce3+ ions. As particles become small 
increased lattice strain affects oxygen vacancy defects nearby the surface of the crystal [58]. While 
the absolute value of the lattice parameter a as a function of the particle size did not agree with all 
literature the trend throughout was similar. This finding substantiates the idea that the lattice 
parameter of iron doped cerium oxide particles is representative of two phenomena; the inclusion 
of Fe3+ ions and the production of Ce3+ ions. 
 
Figure 4-6: Oxygen vacancy defects increase with reduced crystal size.   
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4.2 Cerium oxide particles by spray pyrolysis 
4.2.1 Synthesis 
 
Figure 4-7: Cerium oxide particles formed by spray pyrolysis at 700 °C 
Spray pyrolysis proved to be a less efficient method of synthesis than co-precipitation with an 
average yield of 60 % compared to 90 % for co-precipitation. What the synthesis process lacked in 
yield it made up for in sheer output as 80 g of finished product was produced in less than two days. 
More importantly the synthesis was able to produce small crystalline particles at far greater output 
than co-precipitation without a need for any further annealing. The particles were extremely dry 
and had a talc-like quality. Scanning electron microscope (SEM) analysis performed by a colleague 
showed the particles to be hollow spherical particles of 2-5 µm in diameter. During XRD studies pure 
cerium oxide particles were found to be very hygroscopic with the trait reducing as iron doping 
increased. The hygroscopic nature of cerium oxide particles is most probably due to uptake of water 
molecules in oxygen vacancies at the surface of the constituent crystals.   
Pure 5 % Fe 10 % Fe 20 % Fe 
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A reduction in hygroscopicity with the inclusion of Fe3+ iron suggests a reduction in these OVDs. 
While it is expected that Fe3+ ions will force oxygen vacancies in the lattice the uptake of oxygen 




Figure 4-8: XRD reflection patterns for pure (a), 5% Fe doped (b), 10% Fe doped (c) and 20% Fe doped (d) cerium 
oxide particles synthesised by spray pyrolysis. 
Studies of the x-ray diffraction patterns shown in Figure 4-8 report all particles to be of a single 
cubic-fluorite phase. The pattern was identified as cerium oxide and no evidence of haematite or 
maghemite crystals could be found.  The broad peaks are consistent with small constituent 
crystallites.  
Chapter 4: Results and Discussion   46 
 
As was the case with co-precipitation particles the following generalities could be found and are 
captured in Table 4-1: 
• all crystals were of cubic-fluorite arrangement. 
• the lattice parameter, a, reduced with increased crystal size. 
• increasing the atomic concentration of iron reduced the lattice parameter, a  
Of interest though was the size of crystals and the magnitude of the lattice parameter. Even though 
crystallisation occurred at 700 ⁰C crystals were small (< 10 nm) and the lattice parameter for all 
particles well above bulk suggesting the formation of significant amounts of OVDs. This finding 
confirmed spray pyrolysis to be a superior synthesis method for the production of nanocrystalline 
cerium oxide particles.  Furthermore, the doping outcome of the synthesis was excellent with actual 
atomic doping within 0.5 % of target for all particles except the 20 % iron doped variant. The loss of 
over 1 % atomic iron coupled with the plateauing of the lattice parameter at 5.416 Å suggests the 
solubility of iron within the cerium oxide crystal had been reached. Previously a solubility limit of 
between 10-20 % had been reported by Truffault et al. [59]. At such high crystallisation 
temperatures it’s highly likely that the iron was evaporated at the head of the head of the oven.  
Particle Atomic composition by ICP-OES                         






Pure 99.8 ± 0.3  0.23 ± 0.01 700 7 - 10 5.428 
5% Fe 95.3 ± 0.4  4.74 ± 0.02 700 6 - 9 5.419 
10% Fe 90.4 ± 0.3  9.57 ± 0.04 700 5 - 8 5.416 
20% Fe 81.1 ± 0.5 18.91 ± 0.01 700 5 - 7 5.416 
 
Table 4-1: Synthesis and structure of spray pyrolysis cerium oxide particle 
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As seen previously Fe3+ ion inclusion reduces crystallite size most likely due to its reduced co-
ordinate geometry and the distortion of the lattice as a result of its smaller ionic radius. Again, the 
lattice parameter a for each particle must be consider to be a net outcome from the inclusion of 
Fe3+ ions and the generation of Ce3+ ions as a result strain within crystals. 
 
Figure 4-9: TEM image of pure cerium oxide nanoparticle (~ 40 nm) made up of small crystals (~ 10 nm). The 
highlighted yellow is 2 crystals co-joined. The smaller crystal approximated at 8 nm.  
The initial goal of TEM was to verify crystallite size and lattice parameter. However, it became 
quickly apparent that the sintered aggregation of crystals would be a roadblock to this objective. 
Compounding this was the blurring of images caused by earthworks in the adjacent block to ISEM. 
This affected all iron doped nanoparticles as images were taken on a separate day to the pure cerium 
oxide nanoparticles. There were enough useful images to confirm the effectiveness of the new 
sonication method with particles as small as 30-50 nm seen, but not imaged for all particles; pure 
and iron doped. In Figure 4-9  is a pure cerium oxide nanoparticle of ~ 40 nm diameter made up of 
small crystals of ~ 10 nm dimension. The highlighted yellow is 2 crystals co-joined.  
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The smaller crystal approximated at 8 nm. The small amount of exposed crystals imaged, like that 
outlined yellow above had dimensions consistent with those determined by XRD.  Due to the 
disinclination of the fused boundaries determination of lattice parameters was not possible.  
 
Figure 4-10: XPS spectra for Ce 3d binding energy peaks – pure cerium oxide nanoparticles. 
The bulk cerium oxide spectra possesses 6 orbital peaks due to d-splitting caused by the interaction 
of the oxygen 2p valence band with the Ce 4f electron band [60]. This makes it extremely difficult 
to identify the spin-orbital components peaks of the Ce3+ ion. Figure 4-10 shows the Ce3d spectra 
to be very crowded with the Ce4+ triplet for the 3d5/2 energy state (D, E, F) overlapping the Ce4+ 
triplet for the 3d3/2 energy state (A,B,C) with the Ce3+ doublet for the 3d5/2 energy state (I,J) and the 
Ce3+ doublet for the 3d3/2 energy state (G,H) to be found amongst them. 
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Figure 4-11: Ce 3d XPS spectra of pure (a), 5 % Fe (b), 10 % Fe (c) and 20 % Fe doped nanocrystalline particles.  
18.2 % Ce3+ 
15.9 % Ce3+ 
12.5 % Ce3+ 
8.5 % Ce3+ 
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To determine Ce ion portions the background was removed using Shirley subtraction and spin-orbit 
components peaks built as described in Table 3-3. The results were as expected with pure CeOx NPs 
possessing the largest atomic population of Ce3+ ions at 18.2% with populations trending to a 
minimum of 8.5% for the 20 % iron doped cerium oxide particle. A greater comparative analysis of 
the Ce3d survey spectra for all CeOx NP (Figure 4-11) identify diminishing peaks at 900.8 and 
882.3 eV. The diminishing peaks are within 2-3 eV of peaks G and I suggesting the involve of the Ce3+ 
doublets and a reducing population of Ce3+ ions with increased Fe3+ ions. 
4.2.3 Cell growth 
 
Figure 4-12: 9L cell growth with cerium oxide nanoparticle inclusions. Survival fractions were normalised to a 9L 
control, averages determined from a sample size of 2 and errors given as ± 1 standard deviation from the mean. 
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It was found that pure and 5 % iron doped cerium oxide nanoparticles boosted cell growth while 
10% iron doped cerium oxide nanoparticles had no statistically significant effect. The survival 
fraction for each nanoparticle inclusion was 1.10 ± 0.04 (1SD), 1.06 ± 0.04 (1SD) and 0.98 ± 0.01 (1 SD) 
respectively.  
It should be noted that the survival fractions of pure and 5% Fe doped CeOx NP inclusions were not 
statistically significant. However, the trend of diminishing cell growth in figure 4-12 is significant and 
consistent with modulated antioxidant capacity. Increasing iron levels reduces lattice strain and the 
number of oxygen vacancies forming in the crystal. The trend supports early work demonstrating a 
direct correlation between the trivalent oxidation state of CeOx NPs and superoxide-dismutase 
mimetic-activity [61]. The 20% iron doped cerium oxide nanoparticle possessed mild toxicity 
reducing the survival fraction to 0.88 ± 0.02 (1SD). This result was not unexpected as characterisation 
of the NP suggested a small amount of interstitial hematite or maghemite forming throughout the 
NP. Previous investigation by Cardillo had shown maghemite to be quite toxic to the 9L cell line [62].  
 
4.2.4 Radiation Protection 
Due to a sudden and sustained deterioration of 9L cell line health towards the end of investigations 
it was only possible to produce survival curves for the 9L control and the pure CeOx NP inclusion 
(Figure 4-13). A complete study of radioprotection for all nanoparticle inclusions was achieved 
instead by comparing survival fractions at a single dose of 8Gy (Figure 4-14).   
The protection afforded by the pure CeOx NP inclusion is evident by the increased shoulder of the 
9L + pure NP curve compared to the 9L control curve. This increased shoulder suggests an increased 
portion of cells sustained sub lethal damage at lower doses (< 5 Gy) and were able to repair over the 
3 weeks of incubation.  
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A linear- quadratic fit of the curves reports α/β ratios of 6.32 for the 9L control versus 2.80 for the 
9L + pure CeOx NPs. The increased radioresistance of this cell line series was confirmed with a PER 
of 1.22. At 10% survival fraction the 9L control line could sustained 8.39 Gy while the NP inclusion a 
larger 10.22 Gy. This finding is similar to that reported by Briggs, 2013 [48]. Brigg's PER of 1.26 was 
achieved will slightly smaller cerium oxide nanoparticles possessing slightly smaller crystals of 4-
7 nm. The smaller size of these crystals should improve free radical scavenging [63]. However, the 
particles were annealed at a much lower temperature of 500 ⁰C. It’s possible that nitrates left behind 
during synthesis gave these nanoparticles a slight cytotoxicity which countered the positive 
scavenging effect [64] resulting in a reduced overall improvement.  
 
Figure 4-13: Survival curves of 9L control and CeOx NP inclusion for 10MV x-rays. Survival fractions were 
normalised to 9L control, averages determined from a sample size of 2 and errors given as ± 1 standard 
deviation from the mean. 
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The radioresistance of the 9L cell line is attributed to the proliferation of cells themselves. The large 
number of cells lower the pH of the media through the contribution of metabolic waste compounds 
such as lactic acid and carbon dioxide which in turn reduce the amount of dissolved oxygen in the 
media [65]. This acidic shift is seen as a change in the media colour from purple to orange (pH=8.5 
→ pH=7.5). The reduced oxygen levels should result in the formation of fewer reactive oxygen 
species during the megavoltage irradiation [66]. 
 
Figure 4-14: Surviving fraction of 9L cells for cerium oxide nanoparticles after delivery of 8 Gy absorbed dose. 
SF were normalised to 9L control, averages determined from a sample size of 2 and errors given as ± 1 standard 
deviation from the mean. 
Assessing survival curves (Figure 4-13) 8Gy was chosen as the most suitable absorbed dose for 
investigation of radioprotection across all three NP inclusions. Firstly, the difference in survival 
fraction between the 9L control curve and 9L + pure NP curve provided a good range for further 
investigation.  
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Secondly, the absorbed dose was clinically relevant. The use of SABR for local tumour control in sites 
such as lung has seen a large increase in hypo-fractionated therapies [67]. 
The survival fractions for 9L control and 9L with pure, 5 % and 10 % iron doped CeOx NP inclusions 
were 0.118 ± 0.003 (1SD), 0.21 ± 0.03 (1SD), 0.16 ± 0.02 (1SD) and 0.11 ± 0.1 (1SD) respectively. As 
expected, the pure cerium oxide nanoparticle showed a good improvement in survival fraction; 
doubling that of the control. The 5 % iron doped cerium oxide NP also increased the survival fraction 
by 6%, less so than the pure CeOx NP. The 10 % iron doped CeOx NP showed no protection.   
In review it can be seen that radiation protection correlates well with nanoparticle cell growth 
impact. These results are consistent with the hypothesis that radiation protection is dependent on 
the population of Ce3+ ion population in the nanoparticle. 
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Chapter 5  
Conclusion 
The goal of this thesis centred on the anti-oxidant capacity of cerium oxide nanoparticles (CeOx 
NPs), and specifically, to investigate whether this antioxidant dependence translated to radiation 
protection efficacy. The hypothesis of this thesis was that cerium oxide nanoparticles doped with 
iron (Fe3+) to 5 %, 10 % and 20 % atomic concentrations would demonstrate dependence of radiation 
protection efficacy by varying the population of Ce3+ atoms within each particle. 
5.1 Synthesis and characterisation 
The production of pure and iron doped cerium oxide particles by spray pyrolysis was shown to be 
far superior to that of co-precipitation owing to the high output rate, accurate doping, high 
crystallinity and the small size of the constituent crystals making up the CeOx particles (5 – 10 nm). 
80 g of extremely dry particle powder was produced in 2 days with all powders exhibiting talc-like 
consistency; a potential indication of porous structure.  
The porosity of one particle was confirmed by D. Cardillo (09.03.2016) when performing a parallel 
study with BET analysis on the 5 % iron doped CeOx particles determining a specific surface area of 
~ 47 m
2/g. It should be remembered this particle will later be sonicated to a volume some 106 times 
smaller than synthesised, increasing this value immensely.  ICP-OES analysis of chemical 
composition reported minimal contamination and achievement of target doping concentrations to 
within 0.5 % (absolute) for all but the 20% iron doped CeOx particles. The consensus was the 20% 
atomic concentration target was above the solubility limit of cerium oxide as reported in the 
literature [53].  
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Later toxicity studies supported this view as the nanoparticle exhibited mild toxicity on 9L and MDCK 
cell lines; reducing survival fraction respectively to 0.88 ± 0.02 and 0.90 ± 0.03. Through XRD analysis 
all particles were shown to be of a single cubic fluorite phase with a reflection pattern identified as 
that of cerium oxide. The average crystallite size range of 6 - 8 nm in a single dimension was deemed 
acceptable for controlling the population of Ce3+ ions in lattice. TEM imaging of CeOx particles 
confirmed crystallite sizes of 8 ± 1 nm, 7 ± 1 nm, 6 ± 1 nm and 6 ± 1 nm for pure and 5 %, 10 % and 20 % 
CeOx particles respectively.   
Due to a lack of experience in the technology TEM was underutilised resulting in limited structural 
information about all particles. In hindsight, lower magnification SEM images focussing on the size 
and shape of individual crystals and their greater co-ordination within the aggregate would have 
been more informative. A reducing lattice parameter with increased iron doping confirmed the 
inclusion of the Fe3+ ions within the cerium oxide lattice. Rietveld refinement determine the 
minimum lattice parameter to be 5.416 Å; suggesting the production of Ce3+ ion within lattice for all 
particles. 
Investigation of the particles using XPS showed a decreasing population of Ce3+ ions with increasing 
iron doping; from 18.2 % in pure cerium oxide nanoparticles to 8.2 % for the 20 % iron doped variant. 
This trend suggests the inclusion of Fe3+ ions are affecting the population of Ce3+; possibly by 
reducing strain in the crystal lattice and subsequently the number of oxygen vacancy defects. Curve 
fitting component peaks to the Ce3d spectra proved challenging. There was a total of 10 residing 
peaks with 5 of those peaks occupying only 15 eV. In Figure 4-11 the diminishing peaks of the survey 
spectra at 900.8 and 882.3 eV confirm a reduction in Ce3+ ion population.  
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If it were a reduction in Ce4+ ion population it can be reasoned all triplet intensities (3d5/2 and 5d3/2) 
would diminish due to the electronic correlation effect - quantum interplay.  
Reviewing the distribution of all spin-orbit peaks in the 3d spectra (Figure 4-10) and past literature 
it’s the view of the author that a better fit would be achieved if peaks G and I were 3-5 eV lower in 
BE. The possible outcome of this shift would see an increased portion of Ce3+ ions within all particles. 
Unfortunately, at the time of writing, access to XPS analysis software was not possible. Regardless 
of this, the fit of peaks for all particle spectra clearly implies a reduced Ce3+ ion population was 
achieved with increased Fe3+ doping.  Further studies on the Ce3d spectra to arrive at a more 
accurate quantification of cerium 3+ ion concentrations will be conducted in the near future.    
5.2 Biological assessment 
Clonogenic assays using 9L gliosarcoma cells assessed cell growth impact and radiation protection 
efficacy. Pure cerium oxide nanoparticles provided a 10 % boost to cell growth. When irradiated 
with 10 MV x-rays this boost translated to a performance enhancement ratio of 1.22. At 8 Gy the 
pure CeOx NP inclusion improved the radiation survival fraction by 75%, from 0.12 to 0.22. 5% Fe 
doped CeOx NPs improved cell growth by 6% and increased the radiation survival fraction by 20% 
to 0.16. 10% Fe doped CeOx NPs did not significantly affect cell growth or radiation survival fraction. 
As stated previously 20% iron doped NPs were exhibited low/mild toxicity on account of possible 
haematite or maghemite impurities. Overall these studies suggest that radiation protection efficacy 
of cerium oxide nanoparticles is dependent on the population of Ce3+ ions within the crystal lattice 
and is consistent with previous findings.  
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5.3 Future studies 
Glycolysis allows cancer cells to maintain homeostasis and survive under prolonged hypoxia [68]. 
Cancer cells have evolved to favour glycolytic metabolism over oxidative even when there is ample 
supply of oxygen [69]. The production of lactic acid through this metabolic pathway results in a 
comparatively lower local pH than normal tissue. The pH of normal tissue, being closer to neutral, 
is more favourable for free radical scavenging [41]. 
So why then is the 9L cell line, a cancer analog, selective for radioprotection? Most likely this is an 
artefact of the study. At 90% flask confluence the increased lactic output of the 9L cell monolayer 
shifts the basic media solution to neutrality. As cells are metabolic throughout radiation exposure 
and for some time after the pH of the media will remain unchanged till plating. The included cerium 
oxide NPs are actively scavenging throughout this time. The exact reason for this selectivity cannot 
be confirmed at present and the matter warrants future study. 
5.4 Final Statement 
Like all scientific endeavours the success of this investigation hinged on the ability to control 
multiple variables in an attempt to assess the effect of changing just one. In the world of radio-
biology this is not an easy task and at some points in this investigation the best that could be done 
was to assess the global rather than the multitude of variations at the local. However, it is the view 
of the author that this gauge of assessment in no way undermines the integrity of the work 
completed for this study. In review and under scrutiny the evidence collected during this 
investigation supports the hypothesis: 
The radio protection efficacy of cerium oxide nanoparticles is dependent upon the population of Ce3+ 
ion within the crystal lattice. 
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